REG vs STRO
Regency Centers Corporation (REG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
REG does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
REG currently screens at market cap $12.93B and trailing P/E 33.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the REG and STRO stock pages for the full models.
Not investment advice.